How To Build A Sustainable Longevity Company
With Alex Zhavoronkov
Building a sustainable longevity company requires more than a bold mission — it demands a scalable engine for innovation. This talk explores how generative AI and automation are transforming drug and material discovery, compressing timelines from target identification to development candidate nomination, and enabling a new model of biotech that can grow, learn, and compound value over time. Drawing on real-world experience at Insilico Medicine, the session examines the key pillars of sustainability: scientific productivity measured by rigorous benchmarks, a portfolio strategy balancing internal progression with licensing, and an AI platform that improves with every program it runs.